Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 26Unknown 5Terminated 4Recruiting 3Active not recruiting 3Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Breast 1

Conditions

Smoldering Multiple Myeloma 1Sarcopenia 1Neoplasms 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Breast Neoplasms 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Docosahexaenoic Acids × Clear all
NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT06015971 2025-05-06

Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer

Maimónides Biomedical Research Institute of Córdoba

Phase NA Recruiting
40 enrolled

Neoplasms, Sarcopenia

NCT06928701 2025-04-15

NEOMET

University of Eastern Piedmont

Phase NA Recruiting
160 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡